Search results for gsk
GSK announced significant new price reductions for its HIV medicines offered on a not-for-profit basis to the world's poorest countries. This reduction is the fifth time the company has made a price
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline reported its 2007 global giving to charitable initiatives totalled £282 million, equivalent to almost 4% of pre-tax profits for the company (with the FTSE 100 average around 1%). Dona
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline said this morning that a vaccine that could help prevent an outbreak of the H5N1 'bird flu' virus had been approved by the European Commission. The vaccine, Prepandrix, is the first
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Posted by
worldpharmanews
602 days ago
(http://www.worldpharmanews.com)
Category: Research & Development |
Discuss Add this link to... Bury
The draft recommendations announced yesterday by NICE in the second technology appraisal consultation document (ACD) suggest that Tyverb (lapatinib) should not be used in the NHS, except in clinical
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline plc (GSK) has announced that it will acquire the Egyptian mature products business of Bristol Myers Squibb (BMS), for $210 (£125) million, in a move to accelerate sales growth and fur
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Posted by
worldpharmanews
503 days ago
(http://www.worldpharmanews.com)
Category: Research & Development |
Discuss Add this link to... Bury
GlaxoSmithKline to acquire Genelabs Technologies to increase focus on novel small molecule therapies
GlaxoSmithKline [LSE/NYSE: GSK] and Genelabs Technologies, Inc. [NASDAQ: GNLB] have entered into a definitive agreement pursuant to which GSK will acquire Genelabs for approximately $57 million (£35
read more » Discuss Add this link to... Bury
GlaxoSmithKline (GSK) has signed an exclusive Cooperation Agreement with Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (NIBT) as a preliminary step in forming a Joint Venture (JV) between the tw
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline has announced a new global policy to voluntarily stop all corporate political contributions. In the past, GSK - in common with many companies and in full compliance with local laws -
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
